Autism Spectrum Disorder
Autism Spectrum Disorder (ASD) is a neurodevelopmental condition that begins in early childhood, affecting social interaction, communication, and learning, and is characterized by restricted, repetitive behaviors, and varying degrees of sensory sensitivity and social communication challenges. As a spectrum disorder, autism manifests differently in each individual, leading to a wide variation in support needs and abilities.
Health Outcomes
- Altered Neurobiological Markers
- Altered Pyridoxine Concentration
- Changed Functional Connectivity
- Genome Sequencing / Genome Characterization
- Improved ASD Symptoms
- Improved Agility and Coordination Performance
- Improved Analytical Accuracy
- Improved Attention Span
- Improved Autism Behavioral Scores
- Improved Autism Spectrum Disorder Symptoms
- Improved Autistic Disorder
- Improved Behavior
- Improved Behavioral Abnormalities
- Improved Behavioral Symptoms in Younger Children
- Improved Cognitive Behavior
- Improved Cognitive Development
- Improved Cognitive Flexibility
- Improved Communication
- Improved Communication Skills
- Improved Delta Power in EEG
- Improved Developmental Milestone
- Improved Full Scale Intelligence Quotient
- Improved Global Assessment
- Improved Gut-Brain Axis Homeostasis
- Improved Gut-Brain Axis Related Neurobehavioral Measures
- Improved Gut-Brain Axis-Related Neuropsychiatric Health
- Improved Learning
- Improved Mental Developmental Quotient
- Improved Neurobehavioral Function
- Improved Neurological Health
- Improved Neurotransmitter Metabolism
- Improved Opposition and Defiance Behaviors
- Improved Parent/Caregiver Quality of Life
- Improved Performance Developmental Score
- Improved Performance Mastery
- Improved Personal-Social Developmental Score
- Improved Problem-Solving Skills
- Improved Reaction Time
- Improved Set Shifting Ability
- Improved Set-Shifting
- Improved Set-Shifting Reaction Time
- Improved Social Behavior
- Improved Social Emotional Cognition
- Improved Social Function
- Improved Social Functioning
- Improved Social Functioning Quality of Life
- Improved Social Satisfaction
- Improved Socialization
- Improved Specific Elements of ASD Behaviors
- Improved Synaptic Plasticity
- Increased Attachment Gain
- Increased Bifidobacteria Growth
- Increased Bifidobacterium longum Relative Abundance
- Increased Carnosine Level
- Increased Glutathione Level
- Increased Head Circumference
- Increased Oxytocin Synthesis in the Hypothalamus
- Increased Plasma Kynurenic Acid Levels
- Increased Plasma Serotonin Levels
- Increased Postsynaptic Density Protein 95 Levels
- Increased Propionic Acid Levels
- Increased Propionic Acid Production
- Increased Social Avoidance
- Increased Sulfate Metabolite Level
- Maintained Normal Behavior
- Modified Resting-State Brain Connectivity
- Modulated Microbiota-Gut-Brain Axis
- No Change in Plasma GABA Levels
- No Significant Difference Compared to Placebo
- Normalized Neurotransmitter Levels
- Reduced Autism Rating Scale Behavior Subscale Score
- Reduced Autism Rating Scale Score
- Reduced Autism Severity
- Reduced Autism Symptom Severity
- Reduced Autism Treatment Evaluation Checklist Score
- Reduced Autistic-Like Behavioral Symptoms
- Reduced Behavioral Difficulty
- Reduced Brain Inflammation
- Reduced Cortical Excitation
- Reduced D-Lactate Production
- Reduced Food Safety Risk
- Reduced Gilliam Autism Rating Scale Communication Subscale Score
- Reduced Gilliam Autism Rating Scale Socialization Subscale Score
- Reduced Indoleamine 2,3-Dioxygenase Activity
- Reduced Irritability
- Reduced Kynurenine-Tryptophan Ratio
- Reduced Neural Aggregation
- Reduced Neuroinflammatory Markers
- Reduced Oppositional/Defiant Behaviors
- Reduced Perseverative Error
- Reduced Plasma LPS Levels
- Reduced Prefrontal Cortex Oxygenated Hemoglobin
- Reduced Rearing Behavior
- Reduced Repetitive Behaviors
- Reduced Response Time on Flanker Task
- Reduced Serum Malondialdehyde Levels
- Reduced Set-Shifting Reversal Error
- Reduced Stereotypic Behavior
- Reduced Sulphite-Reducing Clostridia
- Regulation of Neuroactive Ligand Receptor Interaction Pathway